showed that coexpression of PD-L1 and CD80 by tumor cells led to reduced detection of PD-L1 on the cell surface and eliminated immunosuppressive effects associated with PD-1/PD-L1 interaction (57). The gene discussed is CD80; the disease is neoplasm.